Universityhospital Ulm
Ulm, 89081, Germany
NCT Number: NCT06182527
This research project aims to investigate the everyday relevance of reactive hypoglycemia (hypoglycemia after a glucose load) in the oral glucose tolerance test (OGTT). Therefore, blood glucose profiles in everyday life will be examined using continuous glucose measurement (Free Style Libre PRO IQ system) over a period of 14 days in affected persons.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Ulm, 89081, Germany
The aim of this analysis is to examine people who underwent an OGTT due to various endocrinological and metabolic issues and developed reactive hypoglycemia, defined as a drop in blood glucose <70mg/dl during the course of the test. During OGTT routine laboratory testing will be performed as part of routine clinical practice. In order to investigate the occurrence and perception of hypoglycaemia in the everyday lives of those affected, their blood glucose profiles will be recorded and evaluated over a period of 14 days.
In addition, the perception of (suspected) hypoglycemia and counteraction will be documented. Anthropometric data will be recorded and a bioelectrical impedance analysis performed to check a correlation with the body composition. Subjects will be recruited via the endocrinology outpatient clinic as part of medical care. To date, very little CGM data are available on the frequency and extent of reactive hypoglycemia in the everyday lives of people without diabetes mellitus. Therefore, 20 subjects with hypoglycemia in the OGTT will be included in this exploratory pilot study for hypothesis generation in order to investigate the occurrence and perception of hypoglycemia in everyday life.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Every participant receives a Free Style Libre Pro IQ sensor for 14 days. Glucose levels will be recorded.
Time frame: 14 days
Occurrence of glucose levels below 70 mg/dl assessed by CGM.
Time frame: 14 days
Number of glucose levels below 70 mg/dl assessed by CGM.
Time frame: 14 days
Non-severe hypoglycemia defined as glucose levels < 70 mg/dl but >= 54mg/dl; severe hypoglycemia defined as glucose levels < 54mg/dl assessed by CGM.
Time frame: 14 days
Occurence of hypoglycemia during day or night time and correspondence to food intake assessed by CGM.
Time frame: 14 days
Incidence of typical symptoms of hypoglycemia perceived by the participant, documented in a protocol with free-text fields handed out to the participant during 1st study visit.
Time frame: 14 days
Time spent in the following glucose ranges: time above range: >140mg/dl; time in range: 71-140mg/dl; time below range: <70mg/dl; time with severe hypoglycemia: <54mg/dl assessed by CGM.
Time frame: 14 days
Mean glucose levels during monitoring period assessed by CGM.
Time frame: 14 days
Glucose variability during monitoring period assessed by CGM.
Time frame: Varying time point between oGTT and 14 days of glucose assessment using CGM
Correlation between severity of hypoglycemia during OGTT and incidence and severity of hypoglycemia in everyday life assessed by CGM.
Time frame: 14 days
Correlation between body composition (assessed by bioelectrical impedance analysis and anthropometric measurements) and incidence as well as severity of hypoglycemia in everyday life assessed by CGM.
University of Ulm
Other
Evaluation of the Everyday Relevance of Reactive Hypoglycemia in the Oral Glucose Tolerance Test Using Continuous Glucose Measurement.
Acronym: HypoCGM
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03353415
Glucose Metabolism Disorders, Hypoglycemia
Boston, Massachusetts, United States
View Trial DetailsNCT05057819
Digestive System Diseases, Dumping Syndrome
Bern, Canton of Bern, Switzerland
View Trial DetailsNCT06986603
Bariatric Surgery, Glucose Metabolism Disorders
Birmingham, Alabama, United States
View Trial DetailsNCT07731165
Glucose Metabolism Disorders, Glycemic Variability
Porto, Porto District, Portugal
View Trial Details